• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于可靠DNA甲基化生物标志物发现的因果关系驱动的候选物识别

Causality-driven candidate identification for reliable DNA methylation biomarker discovery.

作者信息

Tang Xinlu, Guo Rui, Mo Zhanfeng, Fu Wenli, Qian Xiaohua

机构信息

The Medical Image and Health Informatics Lab, the School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.

College of Computing and Data Science, Nanyang Technological University, Singapore, Singapore.

出版信息

Nat Commun. 2025 Jan 15;16(1):680. doi: 10.1038/s41467-025-56054-y.

DOI:10.1038/s41467-025-56054-y
PMID:39814752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11735613/
Abstract

Despite vast data support in DNA methylation (DNAm) biomarker discovery to facilitate health-care research, this field faces huge resource barriers due to preliminary unreliable candidates and the consequent compensations using expensive experiments. The underlying challenges lie in the confounding factors, especially measurement noise and individual characteristics. To achieve reliable identification of a candidate pool for DNAm biomarker discovery, we propose a Causality-driven Deep Regularization framework to reinforce correlations that are suggestive of causality with disease. It integrates causal thinking, deep learning, and biological priors to handle non-causal confounding factors, through a contrastive scheme and a spatial-relation regularization that reduces interferences from individual characteristics and noises, respectively. The comprehensive reliability of the proposed method was verified by simulations and applications involving various human diseases, sample origins, and sequencing technologies, highlighting its universal biomedical significance. Overall, this study offers a causal-deep-learning-based perspective with a compatible tool to identify reliable DNAm biomarker candidates, promoting resource-efficient biomarker discovery.

摘要

尽管在DNA甲基化(DNAm)生物标志物发现方面有大量数据支持以促进医疗保健研究,但由于初步候选物不可靠以及随后使用昂贵实验进行的补偿,该领域面临巨大的资源障碍。潜在的挑战在于混杂因素,尤其是测量噪声和个体特征。为了可靠地识别用于DNAm生物标志物发现的候选池,我们提出了一种因果驱动的深度正则化框架,以加强与疾病存在因果关系的相关性。它整合了因果思维、深度学习和生物学先验知识,通过一种对比方案和一种空间关系正则化来处理非因果混杂因素,分别减少个体特征和噪声的干扰。通过涉及各种人类疾病、样本来源和测序技术的模拟和应用验证了所提方法的综合可靠性,突出了其普遍的生物医学意义。总体而言,本研究提供了一种基于因果深度学习的视角以及一个兼容工具,以识别可靠的DNAm生物标志物候选物,促进资源高效的生物标志物发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d29/11735613/de44daab9cb5/41467_2025_56054_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d29/11735613/1dee1bb181b3/41467_2025_56054_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d29/11735613/01a72508826b/41467_2025_56054_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d29/11735613/0bd4068aaa5c/41467_2025_56054_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d29/11735613/82faaf51f55f/41467_2025_56054_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d29/11735613/de44daab9cb5/41467_2025_56054_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d29/11735613/1dee1bb181b3/41467_2025_56054_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d29/11735613/01a72508826b/41467_2025_56054_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d29/11735613/0bd4068aaa5c/41467_2025_56054_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d29/11735613/82faaf51f55f/41467_2025_56054_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d29/11735613/de44daab9cb5/41467_2025_56054_Fig5_HTML.jpg

相似文献

1
Causality-driven candidate identification for reliable DNA methylation biomarker discovery.用于可靠DNA甲基化生物标志物发现的因果关系驱动的候选物识别
Nat Commun. 2025 Jan 15;16(1):680. doi: 10.1038/s41467-025-56054-y.
2
Investigating causality in the association between DNA methylation and type 2 diabetes using bidirectional two-sample Mendelian randomisation.采用双向两样本孟德尔随机化方法研究 DNA 甲基化与 2 型糖尿病之间的关联中的因果关系。
Diabetologia. 2023 Jul;66(7):1247-1259. doi: 10.1007/s00125-023-05914-7. Epub 2023 May 19.
3
Graph Convolutional Network for AD and MCI Diagnosis Utilizing Peripheral DNA Methylation: Réseau de neurones en graphes pour le diagnostic de la MA et du TCL à l'aide de la méthylation de l'ADN périphérique.利用外周血DNA甲基化的阿尔茨海默病和轻度认知障碍诊断的图卷积网络:使用外周血DNA甲基化进行阿尔茨海默病和轻度认知障碍诊断的图神经网络
Can J Psychiatry. 2024 Dec;69(12):869-879. doi: 10.1177/07067437241300947. Epub 2024 Nov 25.
4
A Deep Survival EWAS approach estimating risk profile based on pre-diagnostic DNA methylation: An application to breast cancer time to diagnosis.基于预诊断 DNA 甲基化的深度生存 EWAS 方法估计风险概况:在乳腺癌诊断时间中的应用。
PLoS Comput Biol. 2022 Sep 26;18(9):e1009959. doi: 10.1371/journal.pcbi.1009959. eCollection 2022 Sep.
5
Group-shrinkage feature selection with a spatial network for mining DNA methylation data.基于空间网络的群组收缩特征选择在挖掘 DNA 甲基化数据中的应用。
Comput Biol Med. 2023 Mar;154:106573. doi: 10.1016/j.compbiomed.2023.106573. Epub 2023 Jan 24.
6
Epigenome-wide association study of Chinese monozygotic twins identifies DNA methylation loci associated with estimated glomerular filtration rate.中国同卵双胞胎的表观基因组全关联研究确定了与估计肾小球滤过率相关的DNA甲基化位点。
J Transl Med. 2025 Jan 22;23(1):101. doi: 10.1186/s12967-025-06067-4.
7
Distinct CSF biomarker-associated DNA methylation in Alzheimer's disease and cognitively normal subjects.阿尔茨海默病和认知正常受试者中具有不同 CSF 生物标志物相关性的 DNA 甲基化。
Alzheimers Res Ther. 2023 Apr 10;15(1):78. doi: 10.1186/s13195-023-01216-7.
8
Unidirectional and bidirectional causation between smoking and blood DNA methylation: evidence from twin-based Mendelian randomisation.吸烟与血液DNA甲基化之间的单向和双向因果关系:基于双生子的孟德尔随机化研究证据
Eur J Epidemiol. 2025 Jan;40(1):55-69. doi: 10.1007/s10654-024-01187-5. Epub 2025 Jan 9.
9
A novel framework to build saliva-based DNA methylation biomarkers: Quantifying systemic chronic inflammation as a case study.构建基于唾液的DNA甲基化生物标志物的新框架:以量化全身性慢性炎症为例进行研究
Aging Cell. 2025 Apr;24(4):e14444. doi: 10.1111/acel.14444. Epub 2025 Jan 30.
10
A Linear Regression and Deep Learning Approach for Detecting Reliable Genetic Alterations in Cancer Using DNA Methylation and Gene Expression Data.基于 DNA 甲基化和基因表达数据的线性回归和深度学习方法在癌症中检测可靠的遗传改变。
Genes (Basel). 2020 Aug 12;11(8):931. doi: 10.3390/genes11080931.

引用本文的文献

1
Development and validation of a small-sample machine learning model to predict 5-year overall survival in patients with hepatocellular carcinoma.用于预测肝细胞癌患者5年总生存率的小样本机器学习模型的开发与验证
BMC Cancer. 2025 Jul 1;25(1):1040. doi: 10.1186/s12885-025-14425-0.

本文引用的文献

1
A multiplex blood-based assay targeting DNA methylation in PBMCs enables early detection of breast cancer.一种基于多聚体血液的检测方法,通过检测外周血单核细胞中的 DNA 甲基化,可实现对乳腺癌的早期检测。
Nat Commun. 2023 Aug 7;14(1):4724. doi: 10.1038/s41467-023-40389-5.
2
Blood-based epigenome-wide analyses of 19 common disease states: A longitudinal, population-based linked cohort study of 18,413 Scottish individuals.基于血液的 19 种常见疾病状态的表观基因组全基因组分析:对 18413 名苏格兰个体进行的纵向、基于人群的关联队列研究。
PLoS Med. 2023 Jul 6;20(7):e1004247. doi: 10.1371/journal.pmed.1004247. eCollection 2023 Jul.
3
A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancer.
用于预测 II 期结直肠癌肿瘤复发的 DNA 甲基化特征。
Br J Cancer. 2023 May;128(9):1681-1689. doi: 10.1038/s41416-023-02155-8. Epub 2023 Feb 24.
4
Peripheral blood DNA methylation profiles predict future development of B-cell Non-Hodgkin Lymphoma.外周血DNA甲基化谱可预测B细胞非霍奇金淋巴瘤的未来发展。
NPJ Precis Oncol. 2022 Jul 21;6(1):53. doi: 10.1038/s41698-022-00295-3.
5
DNA methylation-based predictors of health: applications and statistical considerations.基于 DNA 甲基化的健康预测指标:应用和统计考虑。
Nat Rev Genet. 2022 Jun;23(6):369-383. doi: 10.1038/s41576-022-00465-w. Epub 2022 Mar 18.
6
EGFR DNA Methylation Correlates With EGFR Expression, Immune Cell Infiltration, and Overall Survival in Lung Adenocarcinoma.表皮生长因子受体(EGFR)DNA甲基化与肺腺癌中的EGFR表达、免疫细胞浸润及总生存期相关。
Front Oncol. 2021 Aug 10;11:691915. doi: 10.3389/fonc.2021.691915. eCollection 2021.
7
Calling differentially methylated regions from whole genome bisulphite sequencing with DMRcate.使用DMRcate从全基因组亚硫酸氢盐测序中识别差异甲基化区域。
Nucleic Acids Res. 2021 Nov 8;49(19):e109. doi: 10.1093/nar/gkab637.
8
Computational Drug Repurposing for Alzheimer's Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies.利用全基因组关联研究(GWAS)和单细胞RNA测序研究中的风险基因进行阿尔茨海默病的药物重定位
Front Pharmacol. 2021 Jun 30;12:617537. doi: 10.3389/fphar.2021.617537. eCollection 2021.
9
Adenocarcinoma spectrum lesions of the lung: Detection, pathology and treatment strategies.肺腺癌谱系病变:检测、病理学和治疗策略。
Cancer Treat Rev. 2021 Sep;99:102237. doi: 10.1016/j.ctrv.2021.102237. Epub 2021 May 29.
10
Epigenome-wide DNA methylation signature of benzo[a]pyrene exposure and their mediation roles in benzo[a]pyrene-associated lung cancer development.苯并[a]芘暴露的全基因组 DNA 甲基化特征及其在苯并[a]芘相关肺癌发生中的中介作用。
J Hazard Mater. 2021 Aug 15;416:125839. doi: 10.1016/j.jhazmat.2021.125839. Epub 2021 Apr 8.